Financing, Equity Capital Markets

Crinetics Pharmaceuticals, Inc.

04/20
|
$115.1 Million
Piper Sandler served as bookrunner for Piper Sandler on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma